X4 Pharmaceuticals, Inc. buy B. Riley
Start price
31.08.23
/
50%
€1.19
Target price
31.08.24
-
Performance (%)
-27.86%
Price
31.05.24
€0.94
Summary
This prediction is currently active. The price of X4 Pharmaceuticals, Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -27.86%. This prediction currently runs until 31.08.24. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
X4 Pharmaceuticals, Inc. | 12.372% | 12.372% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by B__Riley for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "buy" rating re-affirmed by analysts at B. Riley.
Ratings data for XFOR provided by MarketBeat